Blake Lee Neubauer

3.9k total citations · 1 hit paper
55 papers, 2.9k citations indexed

About

Blake Lee Neubauer is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Blake Lee Neubauer has authored 55 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 23 papers in Endocrinology, Diabetes and Metabolism and 22 papers in Molecular Biology. Recurrent topics in Blake Lee Neubauer's work include Hormonal and reproductive studies (22 papers), Prostate Cancer Treatment and Research (21 papers) and Estrogen and related hormone effects (9 papers). Blake Lee Neubauer is often cited by papers focused on Hormonal and reproductive studies (22 papers), Prostate Cancer Treatment and Research (21 papers) and Estrogen and related hormone effects (9 papers). Blake Lee Neubauer collaborates with scholars based in United States, United Kingdom and Spain. Blake Lee Neubauer's co-authors include Jeremy R. Graff, Bruce W. Konicek, Ann M. McNulty, Philip W. Iversen, Robin L. Goode, Gerald R. Cunha, George E. Sandusky, J. M. Shannon, Rebecca L. Lynch and H Fujii and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Blake Lee Neubauer

55 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine

2014 446 citations Lawrence M. Gelbert, Shufen Cai et al. Investigational New Drugs profile →

Peers

Blake Lee Neubauer

PRM

ONCOL

EDM

Elizabeth Buck United States

Jens Hoffmann Germany

M. E. Harper United Kingdom

Gordon Alton United States

Esther Zwick Germany

Jon Curwen United Kingdom

Akiko Kokubu Japan

Antonio Bilancio Italy

Michael Dukes United Kingdom

Richard Kendall United States

Elizabeth Buck United States

Blake Lee Neubauer

1.6k ×1.1

594 ×0.6

PRM

1.1k ×1.4

ONCOL

483 ×1.2

EDM

544 ×1.4

Citations per year, relative to Blake Lee Neubauer Blake Lee Neubauer (= 1×) peers Elizabeth Buck

Countries citing papers authored by Blake Lee Neubauer

Since Specialization

Citations

This map shows the geographic impact of Blake Lee Neubauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blake Lee Neubauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blake Lee Neubauer more than expected).

Fields of papers citing papers by Blake Lee Neubauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Blake Lee Neubauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blake Lee Neubauer. The network helps show where Blake Lee Neubauer may publish in the future.

Co-authorship network of co-authors of Blake Lee Neubauer

This figure shows the co-authorship network connecting the top 25 collaborators of Blake Lee Neubauer. A scholar is included among the top collaborators of Blake Lee Neubauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Blake Lee Neubauer. Blake Lee Neubauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gelbert, Lawrence M., Shufen Cai, Xi Lin, et al.. (2014). Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine. Investigational New Drugs. 32(5). 825–837. 446 indexed citations breakdown →

Graff, Jeremy R., Bruce W. Konicek, Rebecca L. Lynch, et al.. (2009). eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival. Cancer Research. 69(9). 3866–3873. 156 indexed citations

Eisenberger, Mario A., Menachem Laufer, Nicholas J. Vogelzang, et al.. (2004). Phase I and clinical pharmacology of a type I and II, 5-alpha-reductase inhibitor (LY320236) in prostate cancer: elevation of estradiol as possible mechanism of action. Urology. 63(1). 114–119. 14 indexed citations

Johnson, Mac, et al.. (2004). Castration triggers growth of previously static androgen‐independent lesions in the transgenic adenocarcinoma of the mouse prostate (TRAMP) model. The Prostate. 62(4). 322–338. 17 indexed citations

Jiang, Jiazhong, Blake Lee Neubauer, Jeremy R. Graff, et al.. (2002). Expression of Group IIA Secretory Phospholipase A2 Is Elevated in Prostatic Intraepithelial Neoplasia and Adenocarcinoma. American Journal Of Pathology. 160(2). 667–671. 121 indexed citations

Trump, Donald L., Joanne Waldstreicher, Geert J.C.M. Kolvenbag, Paul Wissel, & Blake Lee Neubauer. (2001). Androgen antagonists: Potential role in prostate cancer prevention. Urology. 57(4). 64–67. 18 indexed citations

Graff, Jeremy R., Bruce W. Konicek, Ann M. McNulty, et al.. (2000). Increased AKT Activity Contributes to Prostate Cancer Progression by Dramatically Accelerating Prostate Tumor Growth and Diminishing p27Kip1 Expression. Journal of Biological Chemistry. 275(32). 24500–24505. 320 indexed citations

Abell, Andrew D., et al.. (2000). Simple Bi- and tricyclic inhibitors of human steroid 5α-reductase. Bioorganic & Medicinal Chemistry Letters. 10(17). 1909–1911. 8 indexed citations

Sutkowski, Debra M., Robin L. Goode, Jack Baniel, et al.. (1999). Growth Regulation of Prostatic Stromal Cells by Prostate-Specific Antigen. JNCI Journal of the National Cancer Institute. 91(19). 1663–1669. 69 indexed citations

10.

Smith, Edward C., Loretta A. McQuaid, Robin L. Goode, et al.. (1998). Synthesis and 5α-reductase inhibitory activity of 8-substituted benzo[ƒ]quinolinones derived from palladium mediated coupling reactions. Bioorganic & Medicinal Chemistry Letters. 8(4). 395–398. 16 indexed citations

11.

Kaefer, Martin, James E. Audia, Nicholas Bruchovsky, et al.. (1996). Characterization of type I 5α-reductase activity in DU145 human prostatic adenocarcinoma cells. The Journal of Steroid Biochemistry and Molecular Biology. 58(2). 195–205. 26 indexed citations

12.

Goode, Robin L., et al.. (1995). Prenatal In Vivo Bulbourethral Gland Development Is Not Affected by Prostaglandin E₂ Inhibition. Journal of Andrology. 16(1). 5–11. 3 indexed citations

13.

Neubauer, Blake Lee, Kevin L. Best, David F. Counts, et al.. (1995). Raloxifene (LY156758) produces antimetastatic responses and extends survival in the paiii rat prostatic adenocarcinoma model. The Prostate. 27(4). 220–229. 24 indexed citations

14.

Neubauer, Blake Lee, Kevin L. Best, Thomas R. Blohm, et al.. (1993). LY207320 (6‐methylene‐4‐pregnene‐3,20‐dione) inhibits testosterone biosynthesis, androgen uptake, 5α‐reductase, and produces prostatic regression in male rats. The Prostate. 23(3). 181–199. 8 indexed citations

15.

Neubauer, Blake Lee, Kevin L. Best, James A. Clemens, et al.. (1993). Endocrine and antiprostatic effects of raloxifene (LY156758) in the male rat. The Prostate. 23(3). 245–262. 24 indexed citations

16.

Jones, Charles D., James E. Audia, Loretta A. McQuaid, et al.. (1993). Nonsteroidal inhibitors of human type I steroid 5-.alpha.-reductase. Journal of Medicinal Chemistry. 36(3). 421–423. 77 indexed citations

17.

Sikes, Robert A., Sharon Thomsen, V. Petrow, Blake Lee Neubauer, & Leland W.K. Chung. (1990). Inhibition of Experimentally Induced Mouse Prostatic Hyperplasia by Castration or Steroid Antagonist Administration1. Biology of Reproduction. 43(2). 353–362. 7 indexed citations

18.

Neubauer, Blake Lee, et al.. (1989). Antagonism of androgen and estrogen effects in guinea pig seminal vesicle epithelium and fibromuscular stroma by keoxifene (LY156758). The Prostate. 15(3). 273–286. 10 indexed citations

19.

Steidle, Christopher P., et al.. (1989). Comparative contractile responses among ventral, dorsal, and lateral lobes of the rat prostate. The Prostate. 15(1). 53–63. 7 indexed citations

20.

Smith, Gerald F., Blake Lee Neubauer, Kevin L. Best, et al.. (1988). Correlation of the in vivo anticoagulant, antithrombotic, and antimetastatic efficacy of warfarin in the rat. Thrombosis Research. 50(1). 163–174. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact